Centers for Disease Control and Prevention-led research demonstrates that an oral antiviral drug, 4′-fluorouridine (4′-FlU), effectively inhibits lethal arenavirus infections in animal models.

HOOKIPA’s platform capitalizes on several natural advantages of the arenavirus to deliver differentiated clinical benefits (Fig. 1). First, arenaviruses efficiently target and infect antigen ...